Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22236
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTsimihodimos, V.en
dc.contributor.authorKarabina, S. A.en
dc.contributor.authorTambaki, A.en
dc.contributor.authorBairaktari, E.en
dc.contributor.authorAchimastos, A.en
dc.contributor.authorTselepis, A.en
dc.contributor.authorElisaf, M. S.en
dc.date.accessioned2015-11-24T19:23:03Z-
dc.date.available2015-11-24T19:23:03Z-
dc.identifier.issn0160-2446-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22236-
dc.rightsDefault Licence-
dc.subjectatorvastatinen
dc.subjecthypercholesterolemiaen
dc.subjectcombined hyperlipidemiaen
dc.subjectlipoproteinen
dc.subjectsubtractionsen
dc.subjectlow-density-lipoproteinen
dc.subjectfamilial combined hyperlipidemiaen
dc.subjectcholesterylen
dc.subjectester transferen
dc.subjectb-containing lipoproteinsen
dc.subjectcoronary-heart-diseaseen
dc.subjectmixeden
dc.subjecthyperlipoproteinemiaen
dc.subjectsubfraction distributionen
dc.subjectplasma-lipoproteinsen
dc.subjectdiabetes-mellitusen
dc.subjectartery diseaseen
dc.titleEffect of atorvastatin on the concentration, relative distribution, and chemical composition of lipoprotein sulafractions in patients with dyslipidemias of type IIA and IIBen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1097/00005344-200308000-00021-
heal.identifier.secondary<Go to ISI>://WOS:000184364000021-
heal.identifier.secondaryhttp://graphics.tx.ovid.com/ovftpdfs/FPDDNCLBLGDOOM00/fs042/ovft/live/gv020/00005344/00005344-200308000-00021.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2003-
heal.abstractThe authors investigated the effect of atorvastatin (40 mg qd) on low-density lipoprotein (LDL) particle distribution in patients with dyslipidemias of type IIA (n = 55) and IIB (n = 21). Atorvastatin therapy induced a significant decrease in total and LDL cholesterol in both patient groups. A significant reduction in triglyceride values, which was more profound in type IIB patients, was also observed. In type IIA patients, LDL-3 was the predominant subtraction. Atorvastatin therapy induced a significant reduction in total LDL mass in this group of patients that was mainly due to the reduction in large and intermediate subspecies (LDL-1 to LDL-3), whereas the mass of dense LDL particles (LDL-4 and LDL-5) remained unchanged. As a consequence, the percentage contribution of dense sub-fractions to the total LDL mass increased significantly after atorvastatin therapy. The dense LDL-4 subfraction was the predominant one in type IIB patients. In this group, atorvastatin therapy resulted in a significant reduction in the total LDL mass, which was due to the reduction in all LDL subtractions. Thus, the percentage mass distribution of LDL particles remained unaffected. These results suggest that the effect of atorvastatin on LDL subfractions is affected by the underlying genetic defect.en
heal.journalNameJ Cardiovasc Pharmacolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Tsimihodimos-2003-Effect of atorvastat.pdf337.86 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons